News Roundup: Diabetes Therapies, Omicron Updates


Here’s a roundup of the latest news from Drug Topics®.

This Week in COVID-19: Omicron Spike Leads to Record Case Count

COVID-19 updates and news to know as of January 3, 2022.

SARS-CoV-2 Omicron Variant Displays Genetic Similarities to Common Cold

According to researchers, the Omicron variant developed one of its mutations by picking up a piece of genetic material from the common cold.

Breaking: Boosters Authorized for Children Ages 12-15

The US Food and Drug Administration (FDA) made multiple changes to the emergency use authorization for the Pfizer/BioNTech vaccine.

The Benefits of Co-administering COVID-19, Flu Vaccines

How to educate patients about the safety of receiving the influenza and COVID-19 vaccines at the same time.

Rx for VR: The Role of Virtual Reality in the Pharmacy

A look at how virtual reality is making an impact on pharmacists and patient care.

Patient Education Is Key to Reducing Adverse Effects of OTC Analgesics

Acetaminophen and ibuprofen are accessible over the counter, but do patients know all the risks associated with these medications?

Hybrid Closed-Loop Therapy Improves Diabetes Outcomes, Study Reveals

Automation in closed-loop systems improves type 1 diabetes outcomes and glucose profiles in teens, according to a study published in JAMA Pediatrics.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.